FeaturesSignalPricingFounders
PE

Par Equity

Venture CapitalActive

Par Equity finances early-stage technology companies and is an owner-managed venture capital firm.

Edinburgh, United KingdomFounded 2003parequity.com
61
Investments
3
Exits
$300M
AUM
4.9%
Exit Rate

Get contact info, warm intros & fit scores

Sign up to unlock emails, Signal intro paths, and personalized fit analysis for Par Equity.

Get started free

Investment Thesis & Strategy

Par Equity invests in early-stage technology companies, with a focus on fintech and impact investing, and seeks to partner with owner-managed businesses.

Investment Activity

Deals per year over the last 6 years

1
2017
4
2018
0
2019
1
2020
2
2021
4
2022

Portfolio Companies

Selected investments from their portfolio of 61 companies

x
xDesign
Enterprise · Growth, 2022
Active
B
BioClavis
Biotech · Series A, 2022
Active
R
Raptor Photonics
Other · Growth, 2022
Active
M
M Squared Lasers
Other · Growth, 2022
Active
C
Cytomos
Biotech · Seed, 2021
Active
T
Talking Medicines
Biotech · Series A, 2021
Active
C
ClinSpec Dx
Biotech · Series A, 2020
Active
P
PureLiFi
IoT · Series B, 2018
Active
C
Current Health
Healthcare · Series A, 2018
Active
N
Nanolive
Biotech · Series A, 2018
Active
B
Blackford Analysis
Healthcare · Series A, 2018
Active
S
Snap40
Healthcare · Series A, 2017
Active

Notable Exits

CompanyTypeYearValue / Acquirer
Current HealthAcquisition2021—
MallzeeAcquisition2021—
Snap40Acquisition2020—

Frequently Asked Questions

Par Equity focuses on Series A, Series B, Series C+ stage investments.

Related Investors

Baillie Gifford

Edinburgh, United Kingdom · 83 deals

Old College Capital

Edinburgh, United Kingdom · 23 deals

Sigma Capital Group

Edinburgh, United Kingdom · 16 deals

Apollo Informal Investment

Edinburgh, United Kingdom · 8 deals

Circularity Capital

Edinburgh, United Kingdom · 6 deals

Albany Ventures Fund III

Edinburgh, United Kingdom · 5 deals